Skip to main content
Top
Published in: Familial Cancer 2/2021

01-04-2021 | Colonoscopy | Letter to the Editor

Letter to the Editor-Recent advances in Lynch syndrome: response to Møller et al.

Authors: Leah H. Biller, Sapna Syngal, Matthew B. Yurgelun

Published in: Familial Cancer | Issue 2/2021

Login to get access

Excerpt

We thank the editors for the opportunity to respond to the correspondence by Møller et al. regarding our review “Recent Advances in Lynch Syndrome” [1] published in January 2019. …
Literature
1.
go back to reference Biller LH, Syngal S, Yurgelun MB (2019) Recent advances in Lynch syndrome. Fam Cancer 18(2):211–219CrossRef Biller LH, Syngal S, Yurgelun MB (2019) Recent advances in Lynch syndrome. Fam Cancer 18(2):211–219CrossRef
2.
go back to reference Sanchez A, Navarro M, Ocaña T, Pineda M, Rodriguez-Moranta F, Soriano A et al (2017) Colorectal cancer incidence in Lynch syndrome patients: first report of a multicenter nation-wide study. Gastroenterology 152(5):S552CrossRef Sanchez A, Navarro M, Ocaña T, Pineda M, Rodriguez-Moranta F, Soriano A et al (2017) Colorectal cancer incidence in Lynch syndrome patients: first report of a multicenter nation-wide study. Gastroenterology 152(5):S552CrossRef
3.
go back to reference Engel C, Vasen HF, Seppala T, Aretz S, Bigirwamungu-Bargeman M, de Boer SY, et al. (2018) No difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different Lynch syndrome surveillance policies. Gastroenterology 155(5):1400-9e2CrossRef Engel C, Vasen HF, Seppala T, Aretz S, Bigirwamungu-Bargeman M, de Boer SY, et al. (2018) No difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different Lynch syndrome surveillance policies. Gastroenterology 155(5):1400-9e2CrossRef
4.
go back to reference Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D et al (2018) Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut 67(7):1306–1316CrossRef Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D et al (2018) Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut 67(7):1306–1316CrossRef
5.
go back to reference Dominguez-Valentin M, Seppala TT, Sampson JR, Macrae F, Winship I, Evans DG et al (2019) Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report. Hered Cancer Clin Pract 17:28CrossRef Dominguez-Valentin M, Seppala TT, Sampson JR, Macrae F, Winship I, Evans DG et al (2019) Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report. Hered Cancer Clin Pract 17:28CrossRef
7.
go back to reference Stjepanovic N, Moreira L, Carneiro F, Balaguer F, Cervantes A, Balmana J et al (2019) Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30(10):1558–1571CrossRef Stjepanovic N, Moreira L, Carneiro F, Balaguer F, Cervantes A, Balmana J et al (2019) Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30(10):1558–1571CrossRef
8.
go back to reference Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MW et al (2015) Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol 33(2):209–217CrossRef Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MW et al (2015) Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol 33(2):209–217CrossRef
9.
go back to reference Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, et al (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110(2):223–262 (quiz 63)CrossRef Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, et al (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110(2):223–262 (quiz 63)CrossRef
10.
go back to reference Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW et al (2014) Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol 109(8):1159–1179CrossRef Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW et al (2014) Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol 109(8):1159–1179CrossRef
Metadata
Title
Letter to the Editor-Recent advances in Lynch syndrome: response to Møller et al.
Authors
Leah H. Biller
Sapna Syngal
Matthew B. Yurgelun
Publication date
01-04-2021
Publisher
Springer Netherlands
Keyword
Colonoscopy
Published in
Familial Cancer / Issue 2/2021
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-020-00199-w

Other articles of this Issue 2/2021

Familial Cancer 2/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine